Press release
Herpes Labialis Drugs Market Trends, Business Overview, Industry Growth and Forecast to 2028
The global herpes labialis drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Herpes labialis is a viral infection caused by the herpes simplex virus 1 (HSV-1) this is commonly related to wounds due to cold or herpes simplex virus 2 (HSV-2). Herpes labialis is usually occurred due to swelling of lips and the round facial areas near the mouth. The infection is occurred in childhood and to a certain extent is inactive in the nervous system. There are some serious health issues that can occur in newborn babies or people who have the weak immune system. The growing prevalence of herpes labialis among children and adults across the globe is the factor that is driving the market growth. Herpes labialis is caused by herpes simplex virus type 1 (HSV-1). Therefore, the increase in the herpes simplex infections such as genital herpes is leading to an increasing growth of the market. However, the high cost of treatment and strict government rules and regulations related to drug approval is expected to lower the growth of the market. Also, side effects related use of drugs and people ignoring the treatment for herpes would be a restraint for the growth of the market.Some major players in the market include GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2021, Pfizer Inc. announced the acquisition of Amplyx Pharmaceuticals Inc, a US-based company to help them advance their anti-infective pipeline, and expand their product portfolio of antifungals and antiviral treatments.
Also, in 2020, Perrigo Company Plc announced the launch of its AB-rated Generic Zovirax cream. This product contains acyclovir and can be used to reduce further complications in all types of herpes. In October 2021, United BioPharma, Inc. collaborated with Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology to investigate the efficacy of UB-621, a best-in-class long-acting medication for genital herpes caused by simplex viruses 1 and 2 (HSV 1 and HSV2).
(Get 15% Discount on Buying this Report)
Get Sample Copy of Herpes Labialis Drugs Market at: https://orionmarketreports.com/request-sample/?id=94572&submit=Request+Sample%0D%0A
Market Coverage
•The market number available for - 2021-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Drug Type
•By Route of Administration
•By Distribution Channel
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World
Competitive Landscape- GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., and Pfizer Inc., among others.
A full report Herpes Labialis Drugs Market of is available at: https://orionmarketreports.com/global-herpes-labialis-drugs-market/94572/
Global Herpes Labialis Drug Market Report by Segment
By Drug Type
•Acyclovir
•Valacyclovir
•Penciclovir
•Famciclovir
•Docosanol
By Route of Administration
•Oral
•Topical
•Combination
By Route of Administration
•Hospital Pharmacies
•Retail Pharmacies
•Online Pharmacies
Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Herpes Labialis Drugs Market Trends, Business Overview, Industry Growth and Forecast to 2028 here
News-ID: 2591074 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Herpes
Unlocking Prosperity: Drugs for Herpes Labialis (Oral Herpes) Market Insights
Dive into the pulse of 𝐃𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐇𝐞𝐫𝐩𝐞𝐬 𝐋𝐚𝐛𝐢𝐚𝐥𝐢𝐬 (𝐎𝐫𝐚𝐥 𝐇𝐞𝐫𝐩𝐞𝐬) 𝐌𝐚𝐫𝐤𝐞𝐭 trends with Growth Market Reports latest report! Gain a competitive edge with our in-depth analysis, uncovering market dynamics, consumer behaviors, and strategic imperatives. Let our expertise guide your decision-making and drive success in the ever-evolving landscape. Navigate the trends shaping the landscape and emerge with actionable insights to drive your business forward. Our comprehensive analysis offers a strategic…
Market Mastery: Drugs for Herpes Labialis (Oral Herpes) Market Impact Beyond Exp …
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬, a leading authority in Market analysis, has released an extensive report on the Drugs for Herpes Labialis (Oral Herpes) Market. Tailored for clients seeking new Market dimensions, in-depth product insights, revenue optimization, and strategic reviews of key players, the report provides a roadmap for Market exploration.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐭𝐡𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐃𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐇𝐞𝐫𝐩𝐞𝐬 𝐋𝐚𝐛𝐢𝐚𝐥𝐢𝐬 (𝐎𝐫𝐚𝐥 𝐇𝐞𝐫𝐩𝐞𝐬) 𝐑𝐞𝐩𝐨𝐫𝐭 𝐏𝐃𝐅 @ https://growthmarketreports.com/request-sample/7?utm=Openpr
𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐛𝐲 𝐃𝐫𝐮𝐠𝐬 𝐟𝐨𝐫 𝐇𝐞𝐫𝐩𝐞𝐬 𝐋𝐚𝐛𝐢𝐚𝐥𝐢𝐬 (𝐎𝐫𝐚𝐥 𝐇𝐞𝐫𝐩𝐞𝐬)
𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭…
Herpes Simplex Virus Treatment Market - Unlocking Relief, Conquering Herpes: Red …
Newark, New Castle, USA - new report, titled Herpes Simplex Virus Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Herpes Simplex Virus Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Herpes Simplex Virus Treatment market. The report offers…
Herpes Labialis (Oral Herpes) Market SWOT Analysis by Key Players: BlueWillow Bi …
HTF Market Intelligence released a new research Study of 95 pages on title 'Herpes Labialis (Oral Herpes) - Global Clinical Trials Review, H1, 2021' with in-depth analysis, forecast and business moves. The study covers key regions that includes North America Country (United States, Canada), South America, Asia Country (China, Japan, India, Korea), Europe Country (Germany, UK, France, Italy), Other Country (Middle East, Africa, GCC) and important players such as GlaxoSmithKline…
Global Herpes Labialis (Oral Herpes) Drugs Market Future Analysis Report 2018-20 …
This report studies the global market size of Herpes Labialis (Oral Herpes) Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Herpes Labialis (Oral Herpes) Drugs in these regions.
This research report categorizes the global Herpes Labialis (Oral Herpes) Drugs market by players/brands, region, type and application. This report also studies the global market status, competition…
Drugs For Herpes Labialis (Oral Herpes) Market Demand, Overview, Price and Forec …
ReportBazzar has released its latest research-based report entitled ‘Drugs For Herpes Labialis (Oral Herpes)’ market. This report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Drugs For Herpes Labialis (Oral Herpes) market. The report also provides a detailed analysis of key trends and latest technologies, playing a prominent role in the Drugs For Herpes Labialis (Oral Herpes)…